FindTrial
Sign In

A Study Comparing One-Time IV Ibuprofen and Paracetamol Before Surgery to Reduce Pain After Kidney Stone Removal

Analgesic efficacy of pre-emptive single dose intravenous ibuprofene versus paracetamol for postoperative pain management in percutaneous nephrolithotomy surgery. Aprospective comparative study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/089911
Enrollment
60
Registered
2025-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney Health Condition 2: N200- Calculus of kidney Health Condition 3: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: inj ibuprofen: inj ibuprofen 400 miligram iv 30 minutes before the surgery Control Intervention1: Inj paracetamol: inj paracetamol 1gram iv 30 minutes before the surgery

Sponsors

AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: asa 1 2 and 3 undergoing pcnl

Exclusion criteria

Exclusion criteria: known allergy to given drugs patient with altered renal parameters chronic liver disease peptic ulcer disease gastrointestinal disease psychiatric illness history of opioid and nsaids abuse

Design outcomes

Primary

MeasureTime frame
to comare the analgesic efficacy of pre emptive single dose intrAVENOUS IBUPROFEN AND PARACETAMOL assesing the total consumotion of opoidover 24 hours in post operative period between the groupsTimepoint: to comare the analgesic efficacy of pre emptive single dose intrAVENOUS IBUPROFEN AND PARACETAMOL assesing the total consumotion of opoidover 24 hours in post operative period between the groups—

Secondary

MeasureTime frame
to assess pain using visual analogue scale over 24 hours between the groups to study patient satisfacrtion score at 4 hour and 24 hour btween the groups to study adverse effects over 24 hour between the groups Timepoint: 18 months—

Countries

India

Contacts

Public ContactDr E Shanmugavalli

Aarupadai veedu medical college and hospital

bommidisrk@gmail.com9894723687

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026